BioSyent Inc. (TSXV:RX)
Canada
· Delayed Price · Currency is CAD 10.95
-0.20 (-1.79%)
Apr 1, 2025, 3:59 PM EST
BioSyent Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 7.27 | 6.46 | 5.46 | 6.28 | 3.8 | Upgrade
|
| Depreciation & Amortization | 0.55 | 0.29 | 0.41 | 0.42 | 0.47 | Upgrade
|
| Other Amortization | 0.04 | 0.16 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.43 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.55 | 0.51 | 0.44 | 0.33 | 0.27 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.14 | 0.14 | 0.05 | - | 0.04 | Upgrade
|
| Other Operating Activities | -1.21 | -1.06 | -0.36 | -0.22 | -0.21 | Upgrade
|
| Change in Accounts Receivable | 0.4 | 0.24 | -0.43 | -0.96 | 0.21 | Upgrade
|
| Change in Inventory | 0.57 | -1.48 | -2.44 | -0.13 | 0.07 | Upgrade
|
| Change in Accounts Payable | -1.08 | 0.01 | 1.5 | -0.16 | 0.94 | Upgrade
|
| Change in Unearned Revenue | 0.68 | -0.03 | -0.15 | -0.62 | 0.84 | Upgrade
|
| Change in Income Taxes | 0.29 | -0.21 | 0.22 | -0.15 | 0.1 | Upgrade
|
| Change in Other Net Operating Assets | 0.04 | 0.01 | 0.2 | -0.15 | 0.34 | Upgrade
|
| Operating Cash Flow | 8.66 | 5.05 | 4.95 | 4.67 | 6.89 | Upgrade
|
| Operating Cash Flow Growth | 71.39% | 2.15% | 5.86% | -32.19% | 56.63% | Upgrade
|
| Capital Expenditures | -0.03 | -0.06 | -0.05 | -0.08 | -0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | -4.64 | -0.12 | -0.47 | -0.01 | -0.16 | Upgrade
|
| Investment in Securities | 6.77 | 0.13 | -10.65 | -4.89 | 3.25 | Upgrade
|
| Other Investing Activities | 1.13 | 0.77 | 0.19 | 0.15 | 0.32 | Upgrade
|
| Investing Cash Flow | 3.29 | 0.88 | -10.79 | -4.84 | 3.39 | Upgrade
|
| Long-Term Debt Repaid | -0.18 | -0.17 | -0.16 | -0.15 | -0.14 | Upgrade
|
| Net Debt Issued (Repaid) | -0.18 | -0.17 | -0.16 | -0.15 | -0.14 | Upgrade
|
| Issuance of Common Stock | 0.25 | 0.07 | 0.04 | 0.01 | 0.01 | Upgrade
|
| Repurchase of Common Stock | -5.76 | -3.7 | -3.69 | -1.85 | -3.14 | Upgrade
|
| Common Dividends Paid | -2.08 | -1.91 | -0.48 | - | - | Upgrade
|
| Other Financing Activities | -0.06 | -0.07 | -0.08 | -0.09 | -0.09 | Upgrade
|
| Financing Cash Flow | -7.83 | -5.78 | -4.37 | -2.08 | -3.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0.03 | 0.04 | -0.02 | -0.06 | Upgrade
|
| Net Cash Flow | 4.13 | 0.12 | -10.17 | -2.26 | 6.85 | Upgrade
|
| Free Cash Flow | 8.63 | 5 | 4.9 | 4.59 | 6.88 | Upgrade
|
| Free Cash Flow Growth | 72.76% | 1.91% | 6.79% | -33.29% | 76.55% | Upgrade
|
| Free Cash Flow Margin | 24.64% | 15.81% | 17.55% | 16.04% | 30.81% | Upgrade
|
| Free Cash Flow Per Share | 0.73 | 0.41 | 0.39 | 0.36 | 0.53 | Upgrade
|
| Cash Interest Paid | 0.06 | 0.07 | 0.08 | 0.09 | 0.09 | Upgrade
|
| Cash Income Tax Paid | 2.36 | 2.41 | 1.76 | 2.32 | 1.37 | Upgrade
|
| Levered Free Cash Flow | 3.3 | 4.08 | 3.77 | 3.15 | 6.16 | Upgrade
|
| Unlevered Free Cash Flow | 3.33 | 4.13 | 3.82 | 3.2 | 6.21 | Upgrade
|
| Change in Net Working Capital | -1.01 | 1.43 | 1.01 | 2.68 | -2.45 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.